|
 | HEAT INACTIVATION OF AVIAN INFLUENZA AND NEWCASTLE DISEASE VIRUSES IN EGG PRODUCTS- (06-Jul-04) |
|
| APPLICATION OF NEW VACCINE TECHNOLOGIES FOR THE CONTROL OF TRANSBOUNDARY DISESES- (30-Jun-04) |
|
| ADVANCES IN THE PREVENTION AND CONTROL OF AVIAN INFLUENZA- (10-Mar-04) |
|
| AVIAN INFLUENZA, VACCINES AND CONTROL- (05-Mar-04) |
|
| NEW VACCINE TECHNOLOGIES FOR TRANSBOUNDARY DISEASES- (26-Feb-04) |
|
| SARS - CORONAVIRUS DOES NOT CAUSE DISEASE OR INFECTION IN EXPERIMENTALLY INOCULATED DOMESTIC POULTRY- (26-Nov-03) |
|
| AVIAN INFLUENZA CONTROL STRATEGIES IN THE UNITED STATES OF AMERICA- (27-Oct-03) |
|
| RECOMBINANT PARAMYXOVIRUS TYPE 1-AVIAN INFLUENZA-H7 VIRUS AS A VACCINE FOR PROTECTION OF CHICKENS AGAINST INFLUENZA AND NEWCASTLE DISEASE- (27-Oct-03) |
|
| RECOMBINANT PARAMYXOVIRUS TYPE 1-AVIAN INFLUENZA-H7 VIRUS AS A VACCINE FOR PROTECTION OF CHICKENS AGAINST INFLUENZA AND NEWCASTLE DISEASE- (27-Oct-03) |
|
| RESEARCH INDICATES POULTRY WERE NOT INVOLVED IN SARS OUTBREAK- (22-Oct-03) |
|
| REPORT ON SUBCOMMITTEE ON AVIAN INFLUENZA AND NEWCASTLE DISEASE- (14-Oct-03) |
|
| PASTEURIZATION OF EGG PRODUCTS TO INACTIVATE AVIAN INFLUENZA AND NEWCASTLE DISEASE VIRUSES- (14-Oct-03) |
|
| BIOLOGY OF AVIAN INFLUENZA ESPECIALLY THE CHANGE OF LOW PATHOGENICITY VIRUSES TO HIGH PATHOGENICITY- (15-Sep-03) |
|
| THE FUTURE OF AVIAN INFLUENZA AND NEWCASTLE DISEASE CONTROL- (15-Sep-03) |
|
| VIRAL RESPIRATORY DISEASES OF POULTRY (AI AND NDV FOCUS)- (01-Apr-03) |
|
| VACCINES AND THEIR USE IN CONTROL OR ERADICATION OF AVIAN INFLUENZA- (28-Feb-03) |
|
| VACCINES FOR LIST A POULTRY DISEASES: EMPHASIS ON AVIAN INFLUENZA- (01-Jan-03) |
|
| REPORT ON THE 5TH INTERNATIONAL SYMPOSIUM ON AVIAN INFLUENZA- (23-Oct-02) |
|
| RESEARCH UPDATE ON H7N2 AVIAN INFLUENZA VIRUS IN TURKEYS AND CHICKENS- (23-Oct-02) |
|
| ZOONOSIS UPDATE: AVIAN INFLUENZA AND NEWCASTLE DISEASE- (05-Sep-02) |
|
| VALIDATION OF EGG YOLK ANTIBODY TESTING AS A METHOD TO DETERMINE INFLUENZA STATUS IN WHITE LEGHORN HENS- (12-Feb-02) |
|
| AVIAN INFLUENZA IN EUROPE, ASIA AND CENTRAL AMERICA DURING 2001- (05-Nov-01) |
|
| AVIAN INFLUENZA VACCINE USE- (05-Nov-01) |
|
| GENETICALLY ENGINEERED VACCINES FOR CONTROL OF AVIAN INFLUENZA- (04-Oct-01) |
|
| THE SEARCH FOR AVIAN PNEUMOVIRUS IN WILD BIRDS- (24-Sep-01) |
|
| AVIAN INFLUENZA IN THE WORLD- (01-Sep-01) |
|
| AVIAN INTESTINAL SPIROCHETOSIS- (31-Jul-01) |
|
| INFLUENZA- (13-Jun-01) |
|
| NATIONAL AND INTERNATIONAL AVIAN INFLUENZA OUTBREAKS AND STRATEGIES FOR CONTROL- (01-Jun-01) |
|
| IMPACT OF WEST NILE VIRUS ON THE UNITED STATES POULTRY INDUSTRY- (01-Jun-01) |
|
| NATIONAL AND INTERNATIONAL AVIAN INFLUENZA OUTBREAKS AND STRATEGIES FOR CONTROL- (01-Jun-01) |
|
| WEST NILE VIRUS CAUSES FATAL ENCEPHALITIS AND MYOCARDITIS IN YOUNG DOMESTICGEESE- (01-Mar-01) |
|
| VACCINES PROTECT CHICKENS AGAINST H5 HIGHLY PATHOGENIC AVIAN INFLUENZA IN THE FACE OF GENETIC CHANGES IN FIELD VIRUSES OVER MULTIPLE YEARS- (01-Feb-01) |
|
| EFFICACY OF VACCINES IN CHICKENS AGAINST HIGHLY PATHOGENIC HONG KONG H5N1 AVIAN INFLUENZA- (26-Dec-00) |
|
| A RESEARCH PROGRESS ON POULT ENTERITIS MORTALITY SYNDROME (PEMS) AND AVIAN INFLUENZA- (01-Nov-00) |
|
| PATHOGENICITY OF WEST NILE VIRUS FOR TURKEYS- (07-Aug-00) |
|
| USDA RESEARCH PROGRESS ON AVIAN INFLUENZA, NEWCASTLE DISEASE, AVIAN PNEUMOVIRUS AND POULT ENTERITIS MORTALITY SYNDROME- (01-Nov-99) |
|
| PROTECTION OF CHICKENS BY INACTIVATED AVIAN INFLUENZA VIRUS AND RECOMBINANT FOWL POX VACCINES FROM H5 HIGHLY PATHOGENIC AVIAN INFLUENZA IN THE FACE OF GENETIC CHANGES IN FIELD VIRUSES OVER MULTIPLE YEARS- (01-May-99) |
|
| HIGHLY PATHOGENIC H5 AVIAN INFLUENZA VIRUSES DIFFER IN ABILITY TO INFECT AND PRODUCE DISEASE IN MICE- (08-Apr-99) |
|
| EVOLUTION OF AVIAN INFLUENZA IN GALLINACEOUS BIRDS IN THE LIVE-BIRD MARKET SYSTEM OF THE U.S.- (01-Oct-04) |
|
| STUDIES ON THE REPLICATION OF SARS CORONAVIRUS IN AVIAN SPECIES- (25-Sep-03) |
|
| COMPARATIVE PATHOBIOLOGY OF LOW AND HIGH PATHOGENICITY H7N3 CHILEAN AVIAN INFLUENZA VIRUSES IN CHICKENS- (19-Sep-03) |
|
| PROTECTIVE EFFICACY OF AN INACTIVATED AVIAN INFLUENZA VACCINE AGAINST CHALLENGE WITH A 2002 H7N2 AVIAN INFLUENZA ISOLATE- (01-Jan-03) |
|
| PROTECTIVE EFFICACY OF AN INACTIVATED AVIAN INFLUENZA VACCINE AGAINST CHALLENGE WITH A 2002 H7N2 AVIAN INFLUENZA ISOLATE- (01-Jan-03) |
|
| VARIED PATHOGENICITY OF A HONG KONG-ORIGIN H5N1 AVIAN INFLUENZA VIRUS IN FOUR PASSERINE SPECIES AND BUDGERIGARS- (12-Jul-02) |
|
| SUSCEPTIBILITY OF LAUGHING GULLS (LARUS ATRICILLA) TO A H5N1 AND A H5N3 HIGHLY PATHOGENIC AVIAN INFLUENZA VIRUS- (30-Apr-02) |
|
| VALIDATION OF EGG YOLK ANTIBODY TESTING AS A METHOD TO DETERMINE INFLUENZA STATUS IN WHITE LEGHORN HENS- (12-Mar-02) |
|
| COMPARATIVE SUSCEPTIBILITY OF SELECTED AVIAN AND MAMMALIAN SPECIES TO A HONG KONG-ORIGIN H5N1 HIGHLY PATHOGENIC AVIAN INFLUENZA VIRUS- (12-Mar-02) |
|
| COMPARATIVE SUSCEPTIBILITY OF SELECTED AVIAN AND MAMMALIAN SPECIES TO A HONG KONG-ORIGIN H5N1 HIGHLY PATHOGENIC AVIAN INFLUENZA VIRUS- (05-Feb-02) |
|
| DUAL INFECTION OF TURKEYS WITH NEWCASTLE DISEASE VIRUS AND AVIAN PNEUMOVIRUS COLORADO REPLICATES CLINICAL SIGNS REPORTED IN THE FIELD- (24-Sep-01) |
|
| PATHOBIOLOGY OF A HONG KONG-ORIGIN H5N1 AVIAN INFLUENZA VIRUS IN PIGEONS, GEESE, AND EMUS- (01-Jun-01) |
|
| PATHOGENICITY OF A HONG KONG-ORIGIN H5N1 HIGHLY PATHOGENIC AVIAN INFLUENZA VIRUS FOR EMUS, GEESE, DUCKS, AND PIGEONS- (16-May-01) |
|
| "A/CHICKEN/HONG KONG/22/97 (H5N1): ONE VIRUS, MANY SPECIES"- (27-Feb-01) |
|
| PATHOBIOLOGY OF A/CHICKEN/HONG KONG/220/97 (H5N1) AVIAN INFLUENZA VIRUS IN SEVEN GALLINACEOUS SPECIES- (14-Sep-00) |
|
| CONTINUED CIRCULATION IN CHINA OF HIGHLY PATHOGENIC AVIAN INFLUENZA VIRUSESENCODING THE HEMAGGLUTININ GENE ASSOCIATED WITH THE 1997 H5N1 OUTBREAK IN POULTRY AND HUMANS- (20-Apr-00) |
|
| PRE-CLINICAL EVALUATION OF A LIVE ATTENUATED VIRUS VACCINE BASED ON THE CHIMERIC WEST NILE/DENGUE VIRUS- (09-Jun-04) |
|
| EVALUATION OF A COMMERCIAL AVIAN INFLUENZA (H7N2) VACCINE FOR PROTECTION IN TURKEYS AGAINST AN AVIAN INFLUENZA VIRUS (H7N2) ISOLATED FROM TURKEYS IN VIRGINIA DURING 2002- (01-Jan-04) |
|
| EVALUATION OF A COMMERCIAL AVIAN INFLUENZA (H7N2) VACCINE FOR PROTECTION IN TURKEYS AGAINST AN AVIAN INFLUENZA VIRUS (H7N2) ISOLATED FROM TURKEYS IN VIRGINIA DURING 2002.- (05-Nov-03) |
|
| EVALUATION OF A COMMERCIAL AVIAN INFLUENZA (H7N2) VACCINE FOR PROTECTION IN TURKEYS AGAINST AN AVIAN INFLUENZA VIRUS (H7N2) ISOLATED FROM TURKEYS IN VIRGINIA DURING 2002- (15-Jun-03) |
|
| EVALUATION OF A GENETICALLY MODIFIED REASSORTANT H5N1 INFLUENZA A VIRUS VACCINE CANDIDATE GENERATED BY PLASMID-BASED REVERSE GENETICS- (19-Aug-02) |
|
| AVIAN INFLUENZA VIRUSES IN MINNESOTA DUCKS 1998 - 2000- (01-Mar-02) |
|
| GENERATION AND EVALUATION OF H5N1 AND H9N2 VACCINES FOR PANDEMIC INFLUENZA- (01-Nov-01) |
|
| INFLUENZA IN THE 1990'S- (01-Jun-00) |
|
| DISTINCT PATHOGENESIS OF HONG KONG-ORIGIN H5N1 VIRUSES IN MICE AS COMPARED TO OTHER HIGHLY PATHOGENIC H5 AVIAN INFLUENZA VIRUSES- (28-Oct-99) |
|
| PATHOGENESIS OF HIGHLY VIRULENT AVIAN INFLUENZA A VIRUSES IN MICE AND PROTECTION BY VACCINATION WITH BACULOVIRUS-EXPRESSED HEMAGGLUTININS- (20-Jul-99) |
|
| PATHOGENESIS AND VIRULENCE FACTORS ASSOCIATED WITH HIGHLY VIRULENT H5 AVIAN INFLUENZA A VIRUSES IN MICE- (10-Jul-99) |
|
| SEQUENCE ANALYSIS AND BIOLOGICAL CHARACTERIZATION OF RECENT H5N1 ISOLATES FROM HONG KONG- (21-Jun-99) |
|
| EVIDENCE OF AN ADDITIONAL GLYCOSYLATION SITE AFFECTING THE VIRULENCE OF AVIAN INFLUENZA VIRUSES- (01-Jun-01) |
|
| COMPARISON OF FOUR H7N7 AVIAN INFLUENZA VIRUSES ASSOCIATED WITH INFECTION AND DISEASE IN HUMANS- (10-Nov-00) |
|
| PATHOGENICITY AND IMMUNOGENICITY OF INFLUENZA VIRUSES WITH GENES FROM THE 1918 PANDEMIC VIRUS- (16-Dec-03) |
|
| TOWARDS UNDERSTANDING THE HIGH LETHALITY ASSOCIATED WITH THE 1918 INFLUENZA VIRUS PANDEMIC- (19-Mar-03) |
|
| EXISTING ANTIVIRALS ARE EFFECTIVE AGAINST INFLUENZA VIRUSES WITH GENES FROM THE 1918 PANDEMIC VIRUS- (26-Sep-02) |
|
| SAFETY EVALUATION IN CHICKENS OF CANDIDATE HUMAN VACCINES AGAINST POTENTIAL PANDEMIC STRAINS OF INFLUENZA- (14-Feb-02) |
|
| OUTBREAKS OF HIGHLY PATHOGENIC AVIAN INFLUENZA (H5N2) IN ITALY DURING OCTOBER 1997 TO JANUARY 1998- (15-Apr-99) |
|
| THE GLOBAL HOST IMMUNE RESPONSE: CONTRIBUTION OF HA AND NA GENES FROM THE 1918 SPANISH INFLUENZA TO VIRAL PATHOGENESIS- (21-Apr-04) |
|
| IMMUNOGENICITY OF A FOWL POX VECTORED AI VACCINE: EFFECT OF ADJUVANT AND MULTIPLE IMMUNIZATION IN SEROCONVERSION AND IN PROTECTION VS CHALLENGE WITH HP AVIAN INFLUENZA IN BIRDS WITH PRE-EXISTING FOWL POX IMMUNITY- (01-Jan-04) |
|
| PATHOGENESIS OF AND IMMUNITY TO A RECOMBINANT INFLUENZA VIRUS BEARING THE HEMAGGLUTININ AND NEURAMINIDASE OF THE 1918 PANDEMIC VIRUS- (14-Apr-03) |
|
| ANTIGENIC CROSS-REACTIVITY AMONG AVIAN PNEUMOVIRUSES OF SUBGROUPS A, B, AND C AT THE MATRIX BUT NOT NUCLEOCAPSID PROTEINS- (09-May-02) |
|
| SAFETY EVALUATION IN CHICKENS OF CANDIDATE HUMAN VACCINES AGAINST POTENTIAL PANDEMIC STRAINS OF INFLUENZA- (05-Mar-02) |
|
| CHARACTERIZATION OF RECENT H5 SUBTYPE AVIAN INFLUENZA VIRUSES FROM U.S. POULTRY- (15-Jan-04) |
|
| NDV REAL-TIME RT-PCR TEST DEVELOPMENT, VALIDATION AND USE AS A NATIONAL TEST AT NVSL- (03-Sep-03) |
|
| EVALUATION OF A HIGHLY PATHOGENIC H5N1 AVIAN INFLUENZA A VIRUS ISOLATED FROM DUCK MEAT- (14-Apr-02) |
|
| CHARACTERIZATION OF A HIGHLY PATHOGENIC H5N1 AVIAN INFLUENZA A VIRUS ISOLATED FROM DUCK MEAT- (05-Feb-02) |
|
| CHARACTERIZATION OF A HIGHLY PATHOGENIC H5N1 AVIAN INFLUENZA A VIRUS ISOLATED FROM DUCK SKELETAL MUSCLE- (08-Jan-02) |
|
| SEQUENCE OF THE 1918 PANDEMIC INFLUENZA VIRUS NON-STRUCTURAL GENE (NS) SEGMENT AND CHARACTERIZATION OF RECOMBINANT VIRUSES BEARING THE 1918 NS GENES- (01-Feb-01) |
|
| EPIDEMIOLOGY, PRODUCTION LOSSES, AND CONTROL MEASURES ASSOCIATED WITH AN OUTBREAK OF AI SUBTYPE H7N2 IN PENNSYLVANIA (1996-1998)- (01-Mar-02) |
|
| DIFFERENCES BETWEEN HA RECEPTOR-BINDING SITES OF AVIAN INFLUENZA VIRUSES ISOLATED FROM LARIDAE AND ANATIDAE- (01-May-02) |
Printable version
Email this page
